{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-003344","form_type":"8-K","ticker":"BYSI","cik":"0001677940","company_name":"BeyondSpring Inc.","filed_at":"2026-05-13T11:00:21+00:00","discovered_at":"2026-05-13T11:05:00.322441+00:00","generated_at":"2026-05-13T11:17:06.160736+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BeyondSpring Q1 net loss $2.4M from continuing ops; cash $7.9M; AACR data supports Plinabulin-ADC combo","bullets":["Net loss from continuing operations $2.4M vs $2.6M YoY; discontinued ops loss $4.3M.","Cash and short-term investments $7.9M as of March 31, 2026.","AACR 2026 data: Plinabulin enhances efficacy/tolerability of topoisomerase inhibitor–based ADC regimens.","ST-01156 (RBM39 degrader) advanced to Phase 1; first dose cohort completed.","SEED's operations reported as discontinued due to planned sale of preferred shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003344","json":"https://secwatch.observer/filing/0001171843-26-003344.json","markdown":"https://secwatch.observer/filing/0001171843-26-003344.md","text":"https://secwatch.observer/filing/0001171843-26-003344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677940/000117184326003344/0001171843-26-003344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677940/000117184326003344/f8k_051326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T11:17:06.160736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b88efb394f1384f994be9fdf97631571ec623e50","claim":"BeyondSpring Inc. reported the quarter ended March 31, 2026 results: net income Net loss was $2.4 million.","evidence_excerpt":"On May 13, 2026, BeyondSpring Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677940/000117184326003344/0001171843-26-003344-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Net income","value":"Net loss was $2.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}